Osteoporosis in men—East and West: Can the twain meet? A perspective from Asia
Osteoporosis in men remains a significantly underrecognized condition, with notable differences in bone mineral density (BMD) and fracture risk between Asian and Western populations. Despite 30% of hip fractures globally occurring in men, they are less likely to be diagnosed or treated for osteoporo...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-12-01
|
| Series: | Osteoporosis and Sarcopenia |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2405525524001201 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1846107673544622080 |
|---|---|
| author | Gerald Gui Ren Sng Jean-Yves Reginster Majed S. Alokail Manju Chandran |
| author_facet | Gerald Gui Ren Sng Jean-Yves Reginster Majed S. Alokail Manju Chandran |
| author_sort | Gerald Gui Ren Sng |
| collection | DOAJ |
| description | Osteoporosis in men remains a significantly underrecognized condition, with notable differences in bone mineral density (BMD) and fracture risk between Asian and Western populations. Despite 30% of hip fractures globally occurring in men, they are less likely to be diagnosed or treated for osteoporosis, especially in resource-limited settings. Given these disparities, a deeper understanding of osteoporosis epidemiology and treatment efficacy in men is essential, particularly in Asian populations.This review synthesizes the latest evidence on the epidemiology, screening, and treatment of osteoporosis in men, with a focus on genetic, environmental, and epidemiological disparities between Eastern and Western populations. Additionally, the review examines existing controversies surrounding fracture risk screening in men and evaluates the efficacy and cost-effectiveness of pharmacological treatments such as bisphosphonates, denosumab, and anabolic agents.Asian men exhibit lower peak BMD compared to their Caucasian counterparts, leading to potential misdiagnoses when using Caucasian-based BMD reference ranges. Screening tools like the Fracture Risk Assessment Tool (FRAX)® show variability in performance across populations. Data on pharmacological treatment in men remain limited, although studies suggest comparable benefits to those observed in women. Larger studies, particularly in male and Asian populations, are urgently needed to refine diagnostic and therapeutic guidelines.Osteoporosis in men is underdiagnosed and undertreated globally, with pronounced disparities between populations. Current diagnostic tools and treatment protocols are not fully tailored to male and Asian populations. There is an urgent need for longitudinal studies focusing on male-specific osteoporosis management to reduce fracture risk and improve outcomes. |
| format | Article |
| id | doaj-art-ea7ea17df1a8453683c4b443e3034e70 |
| institution | Kabale University |
| issn | 2405-5255 |
| language | English |
| publishDate | 2024-12-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Osteoporosis and Sarcopenia |
| spelling | doaj-art-ea7ea17df1a8453683c4b443e3034e702024-12-26T08:56:43ZengElsevierOsteoporosis and Sarcopenia2405-52552024-12-01104131144Osteoporosis in men—East and West: Can the twain meet? A perspective from AsiaGerald Gui Ren Sng0Jean-Yves Reginster1Majed S. Alokail2Manju Chandran3Department of Endocrinology, Singapore General Hospital, SingaporeDepartment of Biochemistry, College of Science, King Saud University, Riyadh, Kingdom of Saudi ArabiaDepartment of Biochemistry, College of Science, King Saud University, Riyadh, Kingdom of Saudi ArabiaOsteoporosis and Bone Metabolism Unit, Department of Endocrinology, Singapore General Hospital, Singapore; Duke-NUS Medical School, Singapore; Corresponding author. Department of Endocrinology, Singapore General Hospital, Academia, Level 3, 20 College Road, 169856, Singapore.Osteoporosis in men remains a significantly underrecognized condition, with notable differences in bone mineral density (BMD) and fracture risk between Asian and Western populations. Despite 30% of hip fractures globally occurring in men, they are less likely to be diagnosed or treated for osteoporosis, especially in resource-limited settings. Given these disparities, a deeper understanding of osteoporosis epidemiology and treatment efficacy in men is essential, particularly in Asian populations.This review synthesizes the latest evidence on the epidemiology, screening, and treatment of osteoporosis in men, with a focus on genetic, environmental, and epidemiological disparities between Eastern and Western populations. Additionally, the review examines existing controversies surrounding fracture risk screening in men and evaluates the efficacy and cost-effectiveness of pharmacological treatments such as bisphosphonates, denosumab, and anabolic agents.Asian men exhibit lower peak BMD compared to their Caucasian counterparts, leading to potential misdiagnoses when using Caucasian-based BMD reference ranges. Screening tools like the Fracture Risk Assessment Tool (FRAX)® show variability in performance across populations. Data on pharmacological treatment in men remain limited, although studies suggest comparable benefits to those observed in women. Larger studies, particularly in male and Asian populations, are urgently needed to refine diagnostic and therapeutic guidelines.Osteoporosis in men is underdiagnosed and undertreated globally, with pronounced disparities between populations. Current diagnostic tools and treatment protocols are not fully tailored to male and Asian populations. There is an urgent need for longitudinal studies focusing on male-specific osteoporosis management to reduce fracture risk and improve outcomes.http://www.sciencedirect.com/science/article/pii/S2405525524001201OsteoporosisAsiaScreeningMenTreatment |
| spellingShingle | Gerald Gui Ren Sng Jean-Yves Reginster Majed S. Alokail Manju Chandran Osteoporosis in men—East and West: Can the twain meet? A perspective from Asia Osteoporosis and Sarcopenia Osteoporosis Asia Screening Men Treatment |
| title | Osteoporosis in men—East and West: Can the twain meet? A perspective from Asia |
| title_full | Osteoporosis in men—East and West: Can the twain meet? A perspective from Asia |
| title_fullStr | Osteoporosis in men—East and West: Can the twain meet? A perspective from Asia |
| title_full_unstemmed | Osteoporosis in men—East and West: Can the twain meet? A perspective from Asia |
| title_short | Osteoporosis in men—East and West: Can the twain meet? A perspective from Asia |
| title_sort | osteoporosis in men east and west can the twain meet a perspective from asia |
| topic | Osteoporosis Asia Screening Men Treatment |
| url | http://www.sciencedirect.com/science/article/pii/S2405525524001201 |
| work_keys_str_mv | AT geraldguirensng osteoporosisinmeneastandwestcanthetwainmeetaperspectivefromasia AT jeanyvesreginster osteoporosisinmeneastandwestcanthetwainmeetaperspectivefromasia AT majedsalokail osteoporosisinmeneastandwestcanthetwainmeetaperspectivefromasia AT manjuchandran osteoporosisinmeneastandwestcanthetwainmeetaperspectivefromasia |